SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
3.070
-0.030 (-0.97%)
At close: Nov 10, 2026, 4:00 PM EST
3.030
-0.040 (-1.30%)
After-hours: Nov 10, 2026, 4:37 PM EST
SAB Biotherapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Oppenheimer No rating | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +356.03% | Nov 6, 2026 |
| Citi | Citi | Buy Maintains $11 | Buy | Maintains | $11 | +258.31% | Nov 6, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $15 | Buy | Reiterates | $15 | +388.60% | Nov 6, 2026 |
| Barclays | Barclays | Buy Maintains $13 | Buy | Maintains | $13 | +323.45% | Nov 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +225.73% | Aug 7, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $14 → $16 | Buy | Reiterates | $14 → $16 | +421.17% | Jun 17, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $6 | Buy | Maintains | $6 | +95.44% | Jun 16, 2026 |
| Jefferies | Jefferies | Buy Initiates $11 | Buy | Initiates | $11 | +258.31% | May 20, 2026 |